6-Mercaptopurine (Mercaptopurine)
1124
relevant articles (147 outcomes,
104 trials/studies)
found for this Drug
Description:
An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia.
Also Known As:
Mercaptopurine; 6 Mercaptopurine; Purinethol; 6 Thiopurine; 1,7-Dihydro-6H-purine-6-thione; 6-Mercaptopurine Monohydrate; 6-Thiohypoxanthine; 6-Thiopurine; BW 57-323H; Glaxo Wellcome Brand of 6-Mercaptopurine; GlaxoSmithKline Brand of 6-Mercaptopurine; Leupurin; Mercaptopurina Wellcome; Puri-Nethol; Purimethol; Wellcome Brand of 6-Mercaptopurine; 6 Mercaptopurine Monohydrate; 6 Thiohypoxanthine; BW 57 323H; BW 57323H; Glaxo Wellcome Brand of 6 Mercaptopurine; GlaxoSmithKline Brand of 6 Mercaptopurine; Puri Nethol; Wellcome Brand of 6 Mercaptopurine; 6H-Purine-6-thione, 1,7-dihydro-
Relationship Network
Drug Context: Research Results